COVID-19 Vaccine Administration

Total Page:16

File Type:pdf, Size:1020Kb

COVID-19 Vaccine Administration 2/4/2021 COVID-19 Vaccine Administration What You Need To Know Navigating the System 1 Take Note RECORDING THIS SESSION 2 1 2/4/2021 Disclosures • There are no planner or presenter Conflicts of Interest for this program 3 Interactivity • Chat box • Question & answers • Polls 4 2 2/4/2021 Connecticut Nurses Association COVID-19 Web Page ASSOCIATION PHILOSOPHY Americans have rated nurses as the #1 most ethical and honest profession, according to the most recent Gallup poll (2020). https://nurse.org/articles/nursing-ranked-most-honest-profession/ 5 COVID-19 Vaccine Webinar Series Webinar # 1 COVID-19 Vaccine: Nurse to Nurse Chat – all about vaccine development and prescribing information (pharmacist-led presentation) Webinar # 2 COVID-19 Vaccine: What You Need to Know- More than a needle in the arm – all about nurses’ role regarding vaccine administration and how mass vaccination clinics work Webinar # 3 COVID-19 Vaccine: What You Need to Know- Navigating the System – all about the different ways nurses can become vaccinators https://ctnurses.org/COVID-19 6 3 2/4/2021 A Little Bit About Yourself In what setting do you currently work? • Hospital (inpatient/outpatient) • Public Health/Community Health • Home Care • Medical Office • Long-Term Care • School System • University/Faculty • Not Currently Working • Retired • Other 7 A Little Bit About Yourself Are you currently working in a COVID-19 vaccination clinic? • Yes, MRC member (volunteer) • Yes, pharmacy • Yes, health system • Yes, federally qualified health center • Not yet, planning to sign up • Not yet, completed DPH survey, waiting to be called • No, just here to learn • Other 8 4 2/4/2021 Tonight's Agenda Answers to Your Questions • WHO is eligible to work in a mass vaccination clinic? • WHAT are the requirements to work as a vaccinator? • WHERE can nurses register to work? • WHEN will I be contacted to work? • WHY should nurses know about Connecticut-specific licensing? • HOW can I get more information to support my work in a mass vaccination clinic? 9 Welcome Christian D. Andresen, MPH, CPH Section Chief Practitioner Licensing & Investigations Section Connecticut Department of Public Health Main Phone (860) 509-7552 10 5 2/4/2021 Welcome Marcia B. Proto, M.ED, CAS Executive Director CT League for Nursing & CT Center for Nursing Workforce, Inc. https://ctcenterfornursingworkforce.com/ Upcoming Start Date: April 5, 2021 This 100% online Boot Camp supports licensed nurses with previous Acute Care or Long-Term Care experience who have been out of the nursing workforce for LESS than 10 years and have an ACTIVE RN license to re-enter the workforce. 11 FREE tuition to CT Nurses who qualify. To Register: Contact Peggy Mallick, CLN Program Manager at [email protected] or 203-915-6952 12 6 2/4/2021 I want to be a vaccinator 13 PAID vaccinator VOLUNTEER vaccinator 14 7 2/4/2021 Welcome Joseph Albanese, PhD CT HCC Readiness and Response Coordinator Radiation Biodosimetrist Assist. Clinical Professor of Therapeutic Radiology Yale New Haven Health System Center for Emergency Preparedness and Disaster Response; and Yale University School of Medicine Connecticut Healthcare Coalition - https://cthcc.org/ 15 COVID-19 Vaccinator Registry February 4, 2021 Joseph Albanese, PhD CT HCC Readiness and Response Coordinator Center for Emergency Preparedness and Disaster Response Yale New Haven Health, and Yale School of Medicine 16 8 2/4/2021 Vaccine Allocation January 19 update https://portal.ct.gov/Coronavirus/covid-19-vaccinations 17 Overview of Phase 1b and Timeline 18 9 2/4/2021 Purpose of the Registry . Situational event: COVID-19 vaccine administration for pay • Mitigate potential (anticipated) staffing shortage • Demand limited by vaccine supply . Healthcare professional vaccinators • Actively licensed nurses, physician assistants, physicians • Pay rate set by vaccine provider • Vaccination provider covers liability • Vaccine provider is responsible for vetting vaccinators . Enrollment began January 13 • ~ 2, 000 vaccinators in the first 24 hours • > 12, 000 vaccinators as of today 19 Requested Information at Time of Enrollment . Name and contact info . Medical profession . License number and expiration date . Years of service . Counties willing to work . Shifts willing to work . Enrollment link: https://keysurvey.ynhh.org/f/41544000/1058/ 20 10 2/4/2021 Requesting the Registry 1. Register with www.cthcc.org 2. Wait for confirmation email. Log in with credentials 3. Click registry file to download 21 Welcome Stephanie R. Paulmeno DNP, MS, RN, NHA, CPH, CCM, CDP Public Health Promotion Specialist Greenwich Department of Health Connecticut Nurses’ Association President 22 11 2/4/2021 The Medical Reserve Corps A ZOOM Webinar Presentation to the CT Nurses’ Association Membership: February 4, 2021 6:30 to 7:30 PM Panelist: Stephanie Paulmeno, DNP, MS, RN, NHA, CPH, CCM, CDP Public Health Promotion Specialist: Greenwich Department of Health President: CT Nurses’ Association 23 The Medical Reserve Corps (MRC) A national network of local volunteers MRCs work locally to strengthen public health Reduce community vulnerability Build resiliency & capacity to respond Enhance a community’s preparedness- response Expand a community’s recovery-capacity 24 12 2/4/2021 Historical Perspective of the MRC 2002: President George Bush established the USA Freedom Corps (Post 911 era). The U.S.DHHS launched the MRC as a demonstration project in an effort to engage US citizen-volunteers with health backgrounds to create skilled medical units that could be called into action (42 community-based units were formed) 2006: Congress passed the Pandemic & All Hazards Preparedness Act/created the MRC (500 MRC units were now in place nationwide) 2009/10: 50,000 MRC volunteers responded to the H1N1 Influenza outbreak (immunizations/flu care) 25 2012: Hurricane Sandy inspired 36,000 MRC-volunteer hours in shelters, hospitals, emergency management agencies & DoH providing emergency communications and health education assistance 2014: Ebola in the USA: over 150 MRC units responded to provide 14,000 volunteer hours to case screening, education, and surveillance support 2016: ZIKA in Puerto Rico: Community & public education support was provided to 17,000 people 2017: Multiple Hurricanes: Over 100 MRC units supported dialysis, behavioral health, supportive care, veterinary care, call centers and evacuations. 2018: MRC units responded to California wildfires. They assisted with communications and provided medical services at shelters and evacuation centers 26 13 2/4/2021 2020: COVID-19 Pandemic: Over 400 MRC units across the country responded & are still responding to response efforts in local communities: . COVID Testing . Epidemiology & Surveillance . Contact Tracing . Telehealth monitoring . Medical surge services . Community Screening . Behavioral Health MRC. (n. a.) (2020). Creating Prepared and Resilient Communities: The history of the Medical Reserve Corps Program. ASPR. Department of Health & Human Services/MRC. Retrieved from https://mrc.hhs.gov/file/004_MRC-History-Fact-Sheet_508.pdf. 27 MRC Volunteers Have Options! Work in any one of 10 regions across the country Choose a State or Territory of interest to you Prepare to lead an MRC Unit as a Unit Coordinator Match volunteers’ skills & schedules with the community’s emergency response needs and public health initiatives Register your organization as a partner MRC units work with local hospitals, health departments & other collaborating organizations 28 14 2/4/2021 The Medical Reserve Corps in CT Connecticut has 23 Medical Reserve Corps Units They are grouped into five (5) ESF-Regions Members of the Connecticut Medical Reserve Corps Units include health and public health professionals from many varied backgrounds, support staff, and community citizens who want to participate in a variety of non-medical ways 29 Are YOU Hearing the Clarion Call? “Local health, safety & preparedness begins with you” (CTResponds) As a nurse you have general & unique skills that can benefit your community APRNs & Clinical Nurse Specialists have additional areas of expertise LPNs, RNs, APRN, CNS, Doctorate-Prepared Nurses each have unique gifts to offer; the MRC has room for all Nurses are leaders with knowledge of all other fields of health practice Nurses are THE MOST TRUSTED health practitioners 30 15 2/4/2021 What Does It Mean to be an MRC member? Professional pride and contribution Personal sense of pride and accomplishment Earned respect for valued work Enhanced self-esteem Knowing that you are making a difference Inter/Intra professional collaboration Leadership/fellowship/team “playership” Capacity-building & collaboration-building 31 All MRC Members Are Sworn-in Loyalty Oath “I, _______, do solemnly swear (or affirm) that I will support and defend the Constitution of the United States and the Constitution of the State of Connecticut, against all enemies, foreign and domestic; that I will bear true faith and allegiance to the same; that I take this obligation freely, without any mental reservation or purpose of evasion; and that I will well and faithfully discharge the duties upon which I am about to enter.” CT General Statutes, Title 28-1 32 16 2/4/2021 33 Navigating MRC Web Pages https://ctresponds.ct.gov/ 34 17 2/4/2021 Requirements of MRC Registration Be prepared to show and substantiate your credentials: Current Unencumbered Fill out your form on-line at the CTResponds website Pledge the Loyalty Oath Be an active member: Participate
Recommended publications
  • Vaccinator Training Plan Workstream 4: Vaccine Process and Workforce Subgroup 3: Workforce Planning and Training
    Vaccinator Training Plan Workstream 4: Vaccine Process and Workforce Subgroup 3: Workforce Planning and Training Health Service Executive Vaccinator Training Plan COVID-19 Vaccination Programme Subgroup 3: Workforce Planning and Prepared by Training [New Vaccinator Working Group] David Walsh, Workstream Lead Approved by Vaccination Process and Workforce Date 15th April2021 Version 02 1 Vaccinator Training Plan Workstream 4: Vaccine Process and Workforce Subgroup 3: Workforce Planning and Training Table of Contents Introduction .................................................................................................................................................... 3 Scope of the Training Programme .................................................................................................................. 3 Training Programme Delivery Approach ........................................................................................................ 6 Develop Training Programmes.................................................................................................................... 6 Deliver Vaccinator Training ......................................................................................................................... 7 Delivering the Training .................................................................................................................................... 9 Introduction ...............................................................................................................................................
    [Show full text]
  • Vaccinator Required Pre-Clinic Training
    Vaccinator required pre-clinic training Training (click title to be directed to training PDF or website) Type of Training Page number POD Vaccination Clinic Overview PDF 2 POD Role Description PDF 18 Complete COVID-19 Vaccine Training: General Overview of Web training Web Immunization Best Practices for Healthcare Providers Moderna - CDC’s COVID-19 Vaccine: What Healthcare Web training Web Professionals Need to Know Moderna’s EUA Factsheet for providers PDF 23 Moderna’s EUA Factsheet for recipients PDF 45 Review of information on Moderna’s website Webpage Web Review of CDC’s information on Moderna vaccine Webpage Web Moderna COVID-19 Vaccine; Vaccine Preparation and Webpage Web Administration Summary Pfizer - CDC’s COVID-19 Vaccine: What Healthcare Professionals Web training Web Need to Know Pfizer’s EUA Factsheet for providers PDF 50 Pfizer’s EUA Factsheet for recipients PDF 80 Pfizer-BioNTech COVID-19 Vaccine; Vaccine Preparation and Webpage Web Administration Summary Review CDC’s information on Pfizer’s vaccine Webpage Web Health Department’s Immunization Protocol PDF 86 Health Department’s Medical Orders for COVID-19 Vaccines PDF 89 Health Department’s Bloodborne Pathogen Plan and Appendices PDF 93 2, 4, 5 & 6 Health Department’s Emergency Care and Adverse Event PDF 111 Guidelines Health Department’s Epinephrine Medical Order PDF 116 VAMS Sheet for Healthcare Providers and video attached to email PDF 118 When I Work Training PDF 119 Agency of Human Services HIPAA Awareness Training PDF 132 Review CDC’s Interim Considerations: Preparing
    [Show full text]
  • Oregon's COVID-19 Vaccination Plan
    COVID-19 Vaccination Plan OREGON Oregon Health Authority | Oregon Immunization Program 11/6/2020 | INTERIM DRAFT 1.1 OREGON COVID-19 VACCINATION PLAN Table of Contents Record of Changes ..................................................................................................... 3 Introduction: Oregon’s COVID-19 Vaccine Plan ..................................................... 4 Health Equity Definition ............................................................................................ 4 Disproportionate Effects of COVID-19 ..................................................................... 5 Roots of Inequity: Social Determinants of Health and Determinants of Equity .... 5 Communities of Color are Disproportionately Affected by COVID-19 ................ 5 Historical Disparities .............................................................................................. 7 A Path Forward .......................................................................................................... 8 Governor’s Health Equity Framework ................................................................... 8 Co-Creation Process ............................................................................................... 9 Section 1: COVID-9 Vaccination Preparedness Planning .......................................11 Section 2: COVID-19 Organizational Structure and Partner Involvement .............15 Coronavirus Response and Recovery Unit (CRRU) ............................................16 Health Security, Preparedness and
    [Show full text]
  • Ensuring Access to COVID-19 Vaccines for Older Adults and People with Disabilities Who Are Homebound
    Ensuring Access to COVID-19 Vaccines for Older Adults and People with Disabilities Who Are Homebound Recommendations and Considerations for Federal, State, and Local Agencies and their Partners Trust for America’s Health — May 2021 2 Contents Executive Summary ....................................................................................................................................... 3 Background ................................................................................................................................................... 4 Barriers to Ensuring Vaccine Access for Those Who Are Homebound ..................................................... 6 Recommendations and Considerations ........................................................................................................ 7 Prioritize the Homebound Population ...................................................................................................... 9 Define the Homebound Population ........................................................................................................ 10 Equitably Vaccinate People Who Are Homebound ................................................................................ 11 Collect and Utilize Data to Ensure Equitable Access ............................................................................... 13 Proactively Register People Who Are Homebound for Vaccination ....................................................... 13 Develop Flexible and Creative Vaccine Allocation Plans .......................................................................
    [Show full text]
  • ACIP-Vaccinate with Confidence for COVID-19 Vaccine-October 30, 2020
    Vaccinate with Confidence for COVID-19 Vaccines Amanda Cohn, MD October 30, 2020 For more information: www.cdc.gov/COVID19 Rising to the challenge to achieve high coverage with COVID-19 vaccines Influenza Vaccination Coverage, ≥18 years, by Race/Ethnicity: 2008-09 – 2017-18 60 . We need novel and 50 more robust strategies 40 Overall to increase demand and 30 White, NH uptake of COVID-19 20 Black, NH vaccines, once available Percent Vaccinated Percent Hispanic 10 Other* 0 Source: Vaccination Coverage among Adults in the United States, National Health Interview Survey, CDC, 2017. NH = Non-Hispanic. Vaccinations included in this assessment include influenza, pneumococcal, Td, Tdap, Zoster, HepA, HepB, and HPV. 10/27/20 The vaccine demand continuum INCREASING CONFIDENCE IN VACCINE, VACCINATOR, AND HEALTH SYSTEM Vaccination hesitancy: Accept some, delay some, refuse some Demand Refuse Passive all vaccines Acceptance Adapted from source:Source: SAGE GVAP Working Strategic Group onObjective Vaccine Hesitancy 2 Working 2017 Group A new pandemic, a new vaccine, and a new adult- focused platform means shifting tactics . Individuals across the continuum will have concerns. These concerns are understandable and need to be addressed with empathy and transparency. Concerns among healthcare providers is a risk for overall vaccine confidence. Healthcare providers are the most trusted source for health information. Communities will have unique experiences informing COVID-19 vaccine perceptions. Engagement with community organizations and leaders will expand access to clear and accurate information on COVID-19 vaccines. DRAFT A National Strategy to Reinforce Confidence in COVID-19 Vaccines Reinforce Objective: Regularly share clear and accurate COVID-19 vaccine information and take Trust visible actions to build trust in the vaccine, the vaccinator, and the system.
    [Show full text]
  • PREP Act Fact Sheet: Expanding the COVID-19 Vaccination Workforce
    Expanding the COVID-19 Vaccination Workforce COMMITMENT TO ENDING THE COVID- 19 PANDEMIC The federal government is committed to providing enough COVID-19 vaccine for every adult in America who wants to be vaccinated. The Biden Administration is supporting state, local, territorial, and tribal (SLTT) health agencies in administering the vaccines equitably as they become increasingly available. As of March 2021, the U.S. Food and Drug Administration (FDA) has authorized three safe and effective vaccines for emergency use, and federal agencies continue to work with other companies on clinical trials of additional vaccines. Additionally, the federal government has taken significant steps to expand the manufacturing capacity of the authorized vaccines and the supplies needed to administer them. THE NEED FOR VACCINATORS As hundreds of millions more vaccine doses are manufactured and distributed throughout the country, more locations and more healthcare personnel qualified to administer those vaccine doses may be needed. Through the Public Readiness and Emergency Preparedness (PREP) Act Declaration, the federal government has provided a pathway for SLTTs to rapidly expand and support their vaccination workforces as needed – including some healthcare professionals and students in healthcare professions not traditionally in the role of vaccinator and retired healthcare professionals. The PREP Act Declaration should be used by SLTTs to complement other efforts to enhance vaccination awareness and administration, such as health education. In addition, states are encouraged to further expand the categories of persons authorized to administer COVID-19 vaccines in their states, as authorized under the PREP Act, to respond to local needs and availability of potential vaccinators.
    [Show full text]
  • IPV Case Studies in Albania, Tunisia, and Nigeria
    Case Studies of IPV Introduction: Albania, Nigeria, and Tunisia ACKNOWLEDGEMENTS This document is the result of the thinking, collaboration, and hard work of many people. We would like to thank the following group of individuals who played an instrumental role in the writing and review of this document: LEAD AUTHORS Lauren Platt, Katie Gorham, and Lois Privor-Dumm ALBANIA CASE STUDY Silvia Bino, Erida Nelaj, and Iria Preza NIGERIA CASE STUDY Chisom Obi, Shola Molemodile, Ifeyinwa Okoro, Tina Obande, and Chizoba Wonodi TUNISIA CASE STUDY Anne-Marie Giangiulio, Ramzi Ouhichi, Kamal Fahmy, and Essia Ben Farhat Hmida We would also like to thank the numerous people who graciously gave their time to be interviewed for this work and those that helped coordinate the case study, including: ALBANIA Albana Ahmeti, Gazmend Bejtja, Silvia Bino, Evgjeni Kaci, Eduard Kakarriqi, Georgina Kuli-Lito, Erida Nelaj, Iria Preza, and Klodjan Rjepaj NIGERIA Emmanuel Abanida, Toye Abolade, Mallam Bakoji Ahmed, Maryam Ali, Misbau Lawan Didi, Obi Ezebilo, Samuel Jiya, Gideon Kuje, Mustapha Mahmud, Pascal Mkanda, Adamu Nuhu, Abiola Ojumu , Bassey Okposen, Faisal Shuaib, Abdullahi Suleiman, and Salome S. Tor TUNISIA Meha Bergaoui, Nesrine Boujenoui, Abdelkrim Brini, Leila Diffallah, Essia Ben Farhat Hmida, , Ramzi Ouhichi, Nabil Ben Salah, Mme. Sihem, and Mahrez Yahyaoui Funding for this document was provided by Task Force for Global Health through the support of the Bill and Melinda Gates Foundation. TABLE OF CONTENTS Acknowledgements .............................................................................................................2
    [Show full text]
  • Community-Based COVID-19 Vaccination Manual Lessons and Insights from Frontline Operations
    Community-based COVID-19 Vaccination Manual Lessons and insights from frontline operations Photo courtesy of CORE March 2021 Community-based COVID-19 Vaccination Manual Lessons and insights from frontline operations www.coreresponse.org www.pih.org Acknowledgements CORE would like to thank all of our vaccination partners for their tremendous support and collaboration. In Los Angeles: City of Los Angeles, Los Angeles Fire Department, Los Angeles County Department of Public Health, Carbon Health, USC School of Pharmacy, Curative, World Central Kitchen, All Hands and Hearts, Herald Christian Health Center, and our many other critical community partners. Special thanks to the City of LA and the Mayor’s Office for their vision, leadership, and guidance throughout the city’s response to COVID-19. The rapid launch and expansion of testing and vaccination sites across LA, particularly in communities hardest hit by the pandemic, would not have been possible without their dedication and willingness to jump in quickly and fully. To our LAFD brothers and sisters in arms - thank you for setting a model for partnership in emergency response. In Georgia: Atlanta-Fulton County Emergency Management Agency, Fulton County Board of Health, Cobb & Douglas Public Health, and International Rescue Committee. Special thanks to the Georgia Department of Public Health and our county partners for their highly collaborative partnerships and continued commitment to health equity. We would also like to thank our dedicated staff and volunteers across the country who have worked tirelessly on the frontlines serving their communities. Finally, we would like to express our gratitude to our fellow citizens, who have made many sacrifices large and small throughout the pandemic and have done their part to protect each other by masking, social distancing, getting tested, and getting vaccinated.
    [Show full text]
  • Meeting the Challenge of Vaccination Hesitancy
    Foreword by Harvey V. Fineberg and Shirley M. Tilghman This publication is based on work funded in part by the Bill & Melinda Gates Foundation. The findings and conclusions contained within are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation. The Aspen Institute 2300 N Street, N.W. Suite 700 Washington, DC 20037 Sabin Vaccine Institute 2175 K Street, N.W. Suite 400 Washington, DC 20037 ABOUT THE SABIN-ASPEN VACCINE SCIENCE & POLICY GROUP The Sabin-Aspen Vaccine Science & Policy Group brings together senior leaders across many disciplines to examine some of the most challenging vaccine-related issues and drive impactful change. Members are influential, creative, out-of-the-box thinkers who vigorously probe a single topic each year and develop actionable recommendations to advance innovative ideas for the development, distribution, and use of vaccines, as well as evidence- based and cost-effective approaches to immunization. 1 May 2020 We are pleased to introduce the second annual report of the Sabin-Aspen Vaccine Science & Policy Group: Meeting the Challenge of Vaccination Hesitancy. The package of “big ideas” presented here, and the rigorous evidence and consensus-driven insights on which they rest, reassure us that smart strategies are available not only to maintain, restore, and strengthen confidence in the value of vaccines, but also to underscore the broad societal obligation to promote their use. Implementing those strategies requires concerted commitment, and we are deeply grateful to the members of the Vaccine Science & Policy Group, who have helped us identify pathways to progress.
    [Show full text]
  • North Dakota Covid-19 Vaccination Plan
    INTERIM DRAFT NORTH DAKOTA COVID-19 VACCINATION PLAN Updated December 11, 2020 Version 2.0 1 Significant changes from previous version: • Information regarding ancillary supplies provided by federal government • Additional tabletop exercises and other exercises • Updated information regarding the data use agreement with CDC • Tribal sovereignty to determine priority groups • Redistribution guidance • Vaccine finder inventory reporting • Revised phases for vaccination based on ACIP meetings • Long term care federal pharmacy partnership program • Updated tribal preferences for federal or state allocations • Federal pharmacies for Phase 2 • Updated ultra-cold freezer capacity • Revised assumptions for vaccines A and B • Federal government hold of second doses 2 Contents Significant changes from previous version: ......................................................................................... 2 Acronyms ......................................................................................................................................................... 7 Introduction .................................................................................................................................................... 8 Lessons Learned from H1N1 ................................................................................................................ 9 Response Goals for Pandemic Vaccination ................................................................................... 11 COVID-19 Vaccination Planning Assumptions ...........................................................................
    [Show full text]
  • Catalogue of Interventions Addressing Vaccine Hesitancy
    TECHNICAL REPORT Catalogue of interventions addressing vaccine hesitancy www.ecdc.europa.eu ECDC TECHNICAL REPORT Catalogue of interventions addressing vaccine hesitancy This report was commissioned by the European Centre for Disease Prevention and Control (ECDC), under the Framework Service Contract ECDC/2014/013 with World Health Communication Associates (WHCA) and sub- contracted to the London School of Hygiene and Tropical Medicine (LSHTM). It was coordinated by Andrea Würz, with contributions from Irina Ljungqvist and Lucia Pastore Celentano. It was produced by Heidi Larson, Emilie Karafillakis and Clarissa Simas at the London School of Hygiene and Tropical Medicine (LSHTM) – The Vaccine Confidence Project. The following experts were consulted for additional input on interventions addressing vaccine hesitancy: Adriana Baban (Babes-Bolyai University, Romania), Agoritsa Baka (Hellenic Centre for Disease Control and Prevention, Greece), Liesbeth Mollema (National Institute for Public Health and the Environment (RIVM), The Netherlands), Pierluigi Lopalco (University of Pisa, Italy), Pierre Van Damme (University of Antwerp, Belgium), Pierre Verger (National Institute of Health and Medical Research (INSERM), France), Xavier Bosch (Catalan Institute of Oncology (ICO), Spain). Suggested citation: European Centre for Disease Prevention and Control. Catalogue of interventions addressing vaccine hesitancy. Stockholm: ECDC; 2017. Stockholm, April 2017 PDF ISBN 978-92-9498-055-7 doi: 10.2900/654210 Catalogue number TQ-01-17-377-EN-N © European
    [Show full text]
  • Interpersonal Communication for Immunization Training for Front Line Workers
    Facilitator guide Interpersonal Communication for Immunization Training for Front Line Workers UNICEF Europe and Central Asia Region Facilitator guide Interpersonal Communication for Immunization Training for Front Line Workers UNICEF Europe and Central Asia Region 4 Interpersonal Communication for Immunization. Facilitator guide Acknowledgements This training package was developed by the Johns Hopkins Center for Communication Programs, the UNICEF Europe and Central Asia Regional Office, and UNICEF Country Office staff in Bosnia and Herzegovina and Serbia. We would like to thank Sergiu Tomsa, UNICEF Regional Communication for Development Specialist, Mario Mosquera, UNICEF Regional Communication for Development Adviser and Svetlana Stefanet, UNICEF Regional Immunization Specialist, for their significant contributions to its conceptualization and development. We also thank Fatima Cengic, Health and Nutrition Specialist, UNICEF Bosnia and Herzegovina and Jelena Zajeganovic-Jakovljevic, Early Childhood Development Specialist, UNICEF Serbia, as well as Dragoslav Popovic, consultant, the representatives of Institutes of Public Health, academia, health workers, Roma community mediators and civil society organizations from both countries for their support and active engagement in pre-testing and finalizing the package. The materials are based on state-of-the-art resources from UNICEF, the World Health Organization (WHO), European and American Centers for Disease Control, academic journals and the immunization websites of a range of governments
    [Show full text]